Brief: Epigenomics AG Says Plans To Issue Mandatory Convertible Bond In The Amount Of Up To EUR 18.15 Mln
11/06/2021 20:14
June 11 (Reuters) - Epigenomics AG ECXn.DE :
* PLANS TO ISSUE MANDATORY CONVERTIBLE BOND IN THE AMOUNT OF
UP TO
EUR 18.15 MILLION
* MANDATORY CONVERTIBLE BOND WILL CONSIST OF UP TO 181,500
NOTES
WITH A NOMINAL AMOUNT OF EUR 100.00 EACH
* NOTES WILL BE NON-INTEREST-BEARING (ZERO COUPON) AND HAVE
A TERM
UNTIL 2027
* WILL BE CONVERTIBLE INTO UP TO TOTAL OF 15 MLN NO-PAR
VALUE
REGISTERED SHARES,WITH SHARE OF UP TO TOTAL OF EUR 15 MLN IN
CO'S SHARE CAPITAL
Source text for Eikon: ID:nEQ91q0TRa
Further company coverage: ECXn.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns